Frequent gene hypermethylation in laryngeal cancer cell lines and the resistance to demethylation induction by plant polyphenols

Toxicology in Vitro

Volumn 25, Issue 1, 2011, Pages 213-221

  Paluszczak, Jarosław ^a   Krajka Kuźniak, Violetta ^a   Małecka, Zuzanna ^a   Jarmuz, Małgorzata ^b   Kostrzewska Poczekaj, Magdalena ^b   Grenman, Reidar ^c   Baer Dubowska, Wanda ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b INSTITUTE OF HUMAN GENETICS   (Poland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Chemoprevention; DNA methylation; Epigenetics; Larynx cancer; Plant polyphenols

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BIOLOGICAL MARKER; DEATH ASSOCIATED PROTEIN KINASE; GALANGIN; GLUTATHIONE TRANSFERASE P1; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; MYRICETIN; PHLORETIN; POLYPHENOL; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RESVERATROL; RETINOIC ACID RECEPTOR BETA; ROSMARINIC ACID; SINAPIC ACID; SYRINGIC ACID; VON HIPPEL LINDAU PROTEIN;

ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; DRUG TARGETING; EPIGENETICS; GENETIC MARKER; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; LARYNX CARCINOMA; SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS REGULATORY PROTEINS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL SURVIVAL; CINNAMATES; DNA METHYLATION; FEMALE; FLAVONOIDS; GENE SILENCING; GENES, TUMOR SUPPRESSOR; GLUTATHIONE S-TRANSFERASE PI; HEAD AND NECK NEOPLASMS; HUMANS; LARYNGEAL NEOPLASMS; MALE; PHENOLS; PROMOTER REGIONS, GENETIC; RECEPTORS, RETINOIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 78650524204     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2010.11.003     Document Type: Article

References (65)

1. Almadori G., Bussu F., Cadoni G., Galli J., Rigante M., Artuso A., Maurizi M. Multistep laryngeal carcinogenesis helps our understanding of the field cancerisation phenomenon: a review. Eur. J. Cancer 2004, 40:2383-2388.
2. Almadori G., Bussu F., Cadoni G., Galli J., Paludetti G., Maurizi M. Molecular markers in laryngeal squamous cell carcinoma: towards an integrated clinicobiological approach. Eur. J. Cancer 2005, 41:683-693.
3. Alvarez S., Germain P., Alvarez R., Rodríguez-Barrios F., Gronemeyer H., de Lera A.R. Structure, function and modulation of retinoic acid receptor beta, a tumor suppressor. Int. J. Biochem. Cell. Biol. 2007, 39:1406-1415.
4. Azarschab P., Stembalska A., Loncar M.B., Pfister M., Sa{ogonek}siadek M.M., Blin N. Epigenetic control of E-cadherin (CDH1) by CpG methylation in metastasising laryngeal cancer. Oncol. Rep. 2003, 10:501-503.
5. Bae Y.K., Brown A., Garrett E., Bornman D., Fackler M.J., Sukumar S., Herman J.G., Gabrielson E. Hypermethylation in histologically distinct classes of breast cancer. Clin. Cancer Res. 2004, 10:5998-6005.
6. Bazan V., Zanna I., Migliavacca M., Sanz-Casla M.T., Maestro M.L., Corsale S., Macaluso M., Dardanoni G., Restivo S., Quintela P.L., Bernaldez R., Salerno S., Morello V., Tomasino R.M., Gebbia N., Russo A. Prognostic significance of p16INK4a alterations and 9p21 loss of heterozygosity in locally advanced laryngeal squamous cell carcinoma. J. Cell. Physiol. 2002, 192:286-293.
7. Belinsky S.A., Klinge D.M., Stidley C.A., Issa J.P., Herman J.G., March T.H., Baylin S.B. Inhibition of DNA methylation and histone deacetylation prevents murine lung cancer. Cancer Res. 2003, 63:7089-7093.
8. Byun H.-M., Choi S.H., Laird P.W., Trinh B., Siddiqui M.A., Marquez V.E., Yang A.S. 2'-deoxy-N4-[2-(4-nitrophenyl)ethoxycarbonyl]-5-azacytidine: a novel inhibitor of DNA methyltransferase that requires activation by human carboxylesterase 1. Cancer Lett. 2008, 266:238-248.
9. Chang H.W., Ling G.S., Wei W.I., Yuen A.P. Smoking and drinking can induce p15 methylation in the upper aerodigestive tract of healthy individuals and patients with head and neck squamous cell carcinoma. Cancer 2004, 101:125-132.
10. Chuang J.C., Yoo C.B., Kwan J.M., Li T.W.H., Liang G., Yang A.S., Jones P.A. Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2'-deoxycytidine. Mol. Cancer Ther. 2005, 4:1515-1520.
11. Ciu Y., Lu C., Liu L., Sun D., Yao N., Tan S., Bai S., Ma X. Reactivation of methylation-silenced tumor suppressor gene p16INK4a by nordihydroguaiaretic acid and its implication in G1 cell cycle arrest. Life Sci. 2008, 82:247-255.
12. De Stefani E., Boffetta P., Oreggia F., Brennan P., Ronco A., Deneo-Pellegrini H., Mandilaharsu M. Plant foods and risk of laryngeal cancer: a case-control study in Uruguay. Int. J. Cancer 2000, 87:129-132.
13. Dikshit R.P., Gillio-Tos A., Brennan P., De Marco L., Fiano V., Martinez-Penuela J.M., Boffetta P., Merletti F. Hypermethylation, risk factors, clinical characteristics, and survival in 235 patients with laryngeal and hypopharyngeal cancers. Cancer 2007, 110:1745-1751.
14. Dong S.M., Lee E.J., Jeon E.S., Park C.K., Kim K.M. Progressive methylation during the serrated neoplasia pathway of the colorectum. Mod. Pathol. 2005, 18:170-178.
15. Edefonti V., Bravi F., Garavello W., La Vecchia C., Parpinel M., Franceschi S., Dal Maso L., Bosetti C., Boffetta P., Farraroni M., Dacarli A. Nutrient-based dietary patterns and laryngeal cancer: evidence from an exploratory factor analysis. Cancer Epidemiol. Biomarkers Prev. 2010, 19:18-27.
16. Esteller M. Epigenetics in cancer. N. Engl. J. Med. 2008, 358:1148-1159.
17. INK4a, RARβ, and MGMT genes by genistein and other isoflavones from soy. Clin. Cancer Res. 2005, 11:7033-7041.
18. Fang M.Z., Wang Y., Ai N., Hou Z., Sun Y., Lu H., Welsh W., Yang C.S. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res. 2003, 63:7563-7570.
19. Fini L., Selgrad M., Fogliano V., Graziani G., Romano M., Hotchkiss E., Daoud Y.A., De Vol E.B., Boland C.R., Ricciardiello L. Annurca apple polyphenols have potent demethylating activity and can reactivate silenced tumor suppressor genes in colorectal cancer cells. J. Nutr. 2007, 137:2622-2628.
20. Freshney R.I. Culture of Animal Cells: A Manual of Basic Technique 2005, Wiley-Liss, New York. fifth ed.
21. Giefing M., Martin-Subero J.I., Kiwerska K., Jarmuż M., Grenman R., Siebert R., Szyfter K. Characterization of homozygous deletions in laryngeal squamous cell carcinoma cell lines. Cancer Genet. Cytogenet. 2008, 184:38-43.
22. Hasegawa M., Nelson H.H., Peters E., Ringstrom E., Posner M., Kelsey K.T. Patterns of gene promoter methylation in squamous cell cancer of the head and neck. Oncogene 2002, 21:4231-4236.
23. Hermann J.G., Graff J.R., Myohanen S., Nelkin B.D., Baylin S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 1996, 93:9821-9826.
24. Hollenbach P.W., Nguyen A.N., Brady H., Williams M., Ning Y., Richard N., Krushel L., Aukerman S.L., Heise C., MacBeth K.J. A comparison of azacitidine and decitabine activities in acute myeloid leukemia cell lines. PLoS ONE 2010, 5:e9001.
25. Issa J.P. Cancer prevention: epigenetics steps up to the plate. Cancer Prev. Res. 2008, 1:219-222.
26. Issa J.-P., Kantarjian H.M. Targeting DNA methylation. Clin. Cancer Res. 2009, 15:3938-3946.
27. Jarmuż M., Golusiński W., Grenman R., Szyfter K. Analysis of chromosome aberrations in cell lines derived from laryngeal cancer in relation to tumor progression. Eur. Arch. Otorhinolaryngol. 2002, 259:269-273.
28. Jarmuż M., Grenman R., Golusiński W., Szyfter K. Aberrations of 11q13 in laryngeal squamous cell lines and their prognostic significance. Cancer Genet. Cytogenet. 2005, 160:82-88.
29. Kim H., Kwon Y.M., Kim J.S., Lee H., Park J.H., Shim Y.M., Han J., Park J., Kim D.H. Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer. J. Clin. Oncol. 2004, 22:2363-2370.
30. King-Batoon A., Leszczynska J.M., Klein C.B. Modulation of gene methylation by genistein or lycopene in breast cancer cells. Eviron. Mol. Mutagen. 2008, 49:36-45.
31. Kong W.-J., Zhang S., Guo C., Zhang S., Wang Y., Zhang D. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer. Laryngoscope 2005, 115:1395-1401.
32. Kopelovich L., Crowell J.A., Fay J.R. The epigenome as a target for cancer chemoprevention. J. Natl. Cancer Inst. 2003, 95:1747-1757.
33. Krop I., Player A., Tablante A., Taylor-Parker M., Lahti-Domenici J., Fukuoka J., Batra S.K., Papadopoulos N., Richards W.G., Sugarbaker D.J., Wright R.L., Shim J., Stamey T.A., Sellers W.R., Loda M., Meyerson M., Hruban R., Jen J., Polyak K. Frequent HIN-1 promoter methylation and lack of expression in multiple human tumor types. Mol. Cancer Res. 2004, 2:489-494.
34. Krop I., Taylor-Parker M., Bloushtain-Qimron N., Porter D., Gelman R., Sasaki H., Maurer M., Terry M.B., Parsons R., Polyak K. HIN-1, an inhibitor of cell growth, invasion and AKT activation. Cancer Res. 2005, 65:9659-9669.
35. Kulkarni V., Saranath D. Concurrent hypermethylation of multiple regulatory genes in chewing tobacco associated oral squamous cell carcinomas and adjacent normal tissues. Oral Oncol. 2004, 40:145-153.
36. Kwong J., Lo K.W., To K.F., Teo P.M., Johnson P.J., Huang D.P. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Clin. Cancer Res. 2002, 8:131-137.
37. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
38. Lee W.J., Shim J.-Y., Zhu B.T. Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol. Pharmacol. 2005, 68:1018-1030.
39. Lee W.J., Zhu B.T. Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis 2006, 27:269-277.
40. Liu Z., Liu S., Xie Z., Pavlovicz R.E., Wu J., Chen P., Aimiuwu J., Pang J., Bhasin D., Neviani P., Fuchs J.R., Plass C., Li P.K., Li C., Huang T.H.M., Wu L.C., Rush L., Wang H., Perroti D., Marcucci G., Chan K.K. Modulation of DNA methylation by a sesquiterpene lactone parthenolide. J. Pharmacol. Exp. Ther. 2009, 329:505-514.
41. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
42. Majid S., Kikuno N., Nelles J., Noonan E., Tanaka Y., Kawamoto K., Hirata H., Li L.C., Zhao H., Okino S.T., Place R.F., Pookot D., Dahiya R. Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification. Cancer Res. 2008, 68:2736-2744.
43. Majid S., Dar A.A., Ahmad A., Hirata H., Kawakami K., Shahryari V., Saini S., Tanaka Y., Dahiya A.V., Dahiya R. BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis 2009, 30:662-670.
44. Martone T., Gillio-Tos A., De Marco L., Fiano V., Maule M., Cavalot A., Garzaro M., Merletti F., Cortesina G. Association between hypermethylated tumor and paired surgical margins in head and neck squamous cell carcinomas. Clin. Cancer Res. 2007, 13:5089-5094.
45. Maruya S.-I., Issa J.-P.J., Weber R.S., Rosenthal D.I., Haviland J.C., Lotan R., El-Naggar A.K. Differential methylation status of tumor-associated genes in head and neck squamous carcinoma: incidence and potential implications. Clin. Cancer Res. 2004, 10:3825-3830.
46. McCabe M.T., Low J.A., Daignault S., Imperiale M.J., Wojno K.J., Day M.L. Inhibition of DNA methyltransferase activity prevents tumorigenesis in a mouse model of prostate cancer. Cancer Res. 2006, 66:385-392.
47. Ogi K., Toyota M., Ohe-Toyota M., Tanaka N., Noguchi M., Sonoda T., Kohama G., Tokino T. Aberrant methylation of multiple genes and clinicopathological features in oral squamous cell carcinoma. Clin. Cancer Res. 2002, 8:3164-3171.
48. Paluszczak J., Krajka-Kuźniak V., Baer-Dubowska W. The effect of dietary polyphenols on the epigenetic regulation of gene expression in MCF7 breast cancer cells. Toxicol. Lett. 2010, 192:119-125.
49. Paluszczak J., Baer-Dubowska W. Epigenetic diagnostics of cancer: the application of DNA methylation markers. J. Appl. Genet. 2006, 47:365-375.
50. Paz M.F., Fraga M.F., Avila S., Guo M., Pollan M., Herman J.G., Esteller M. A systematic profile of DNA methylation in human cancer cell lines. Cancer Res. 2003, 63:1114-1121.
51. Perez-Ordonez B., Beauchemin M., Jordan R.C.K. Molecular biology of squamous cell carcinoma of the head and neck. J. Clin. Pathol. 2006, 59:445-453.
52. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucl. Acids Res. 2001, 29:e45.
53. Rubinstein J.C., Tran N., Ma S., Halaban R., Krauthammer M. Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma. BMC Med. Genomics 2010, 3:4.
54. Russo A.L., Thiagalingam A., Pan H., Califano J., Cheng K.H., Ponte J.F., Chinnappan D., Nemani P., Sidransky D., Thiagalingam S. Differential DNA hypermethylation of critical genes mediates the stage-specific tobacco smoke-induced neoplastic progression of lung cancer. Clin. Cancer Res. 2005, 11:2466-2470.
55. Sanchez-Cespedes M., Esteller M., Wu L., Nawroz-Danish H., Yoo G.H., Koch W.M., Jen J., Herman J.G., Sidransky D. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res. 2000, 60:892-895.
56. Sa{ogonek}siadek M.M., Stembalska-Kozlowska A., Smigiel R., Ramsey D., Kayademir T., Blin N. Impairment of MLH1 and CDKN2A in oncogenesis of laryngeal cancer. Br. J. Cancer 2004, 90:1594-1599.
57. Streseman C., Brueckner B., Musch T., Stopper H., Lyko F. Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines. Cancer Res. 2006, 66:2794-27800.
58. Streseman C., Lyko F. Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine. Int. J. Cancer 2008, 123:8-13.
59. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 1979, 76:4350-4354.
60. Van Engeland M., Weijenberg M.P., Roemen G.M.J.M., Brink M., de Bruine A.P., Goldbohm R.A., van den Brandt P.A., Baylin S.B., de Goeij A.F.P.M., Herman J.G. Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer. Cancer Res. 2003, 63:3133-3137.
61. Viswanathan M., Tsuchida N., Shanmugam G. Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma. Int. J. Cancer 2003, 105:41-46.
62. Vuillemenot B.R., Pulling L.C., Palmisano W.A., Hutt J.A., Belinsky S.A. Carcinogen exposure differentially modulates RAR-beta promoter hypermethylation, an early and frequent event in mouse lung carcinogenesis. Carcinogenesis 2004, 25:623-629.
63. Yeh K.T., Chang J.G., Lin T.H., Wang Y.F., Tien N., Chang J.Y., Chen J.C., Shih M.C. Epigenetic changes of tumor suppressor genes, P15, P16, VHL and P53 in oral cancer. Oncol. Rep. 2003, 10:659-663.
64. Yoo C.B., Chuang J.C., Byun H.M., Egger G., Yang A.S., Dubeau L., Long T., Laird P.W., Marquez V.E., Jones P.A. Long-term epigenetic therapy with oral zebularine has minimal side effects and prevents intestinal tumors in mice. Cancer Prev. Res. 2008, 1:233-240.
65. Zhang S., Guo C., Kong W., Liu Z. Promoter hypermethylation of DNA repair gene MGMT in laryngeal squamous cell carcinoma. J. Huazhong Univ. Sci. Technolog. Med. Sci. 2006, 26:101-104.